Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight.
Pagibaximab serves as a chimeric monoclonal antibody designed to safeguard against staphylococcal sepsis in premature infants with low birth weight.